Biotechnology News

The United States Patent and Trademark Office has issued a Notice of Allowance for the NanoZolid® technology patent. This will provide additional patent protection for all LIDDS development...

Pressmeddelande 26 mars 2019 Kallelse till årsstämma i Immunicum AB (publ) Aktieägarna i Immunicum AB (publ) ("Bolaget"), org.nr 556629-1786, kallas härmed till årsstämma torsdagen den 25...

Press Release 26 March 2019 Notice of Annual General Meeting in Immunicum AB (publ) The shareholders of Immunicum AB (publ) (the "Company"), reg. no 556629-1786, are hereby invited to the...

Préparation d’une étude clinique évènementielle, randomisée et évaluant la survie globale (SG) aux États-UnisLe retour (pre-IND) de la Food and Drug Administration (FDA) permet de clarifier l’approche...

Moving forward with Overall Survival (OS)-based, randomized, event-driven clinical trial for the United StatesPre-IND feedback from US Food and Drug Administration (FDA) provides clarity to...

Strongest announced preclinical results of any drug candidate currently in development for TBI Significant results in neurobehavior as measured by actigraphy. GRAFTON, Mass., March 25, 2019 (GLOBE...

MINNEAPOLIS, March 25, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announces that it will report Fiscal Year 2018 financial results for...

MINNEAPOLIS, March 25, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (Nasdaq: AIPT) (the “Company”) announced today that at a special meeting of stockholders held on March 22, 2019, the...

WINNIPEG, Manitoba, March 25, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and...

ALAMEDA, Calif., March 25, 2019 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive tests for the early detection of cancer, announced today that it...